Venture capital firm

Merieux Equity Partners

European healthcare-focused investment firm backing companies from start-up stage to established growth businesses

Write a review

Business
Industrial
Science
Europe
+9 more

Visit Website Get introducedRequest an introduction Write a Review

Own this listing? Claim it

TrustList summary

Merieux Equity Partners is an investment firm that specialises in healthcare, life science and nutrition. Created in 2009, it manages capital from outside investors and is registered with the French markets regulator, the AMF.

What Merieux Equity Partners offers

Innovation platform: backs medical innovation from seed stage to series B.
Buyout platform: invests in profitable, fast-growing companies to support their development plans.
Industrial network: gives portfolio companies access to sector expertise and international contacts.

Clients

Healthcare and nutrition companies ranging from start-ups to established players, in Europe and North America. The firm says it has supported more than 45 companies and lists over 60 investments overall. Recent deals include stakes in a French medical technology company, a Spanish biopharmaceutical business and a majority holding in Curea Medical.

Key facts

Founded: 2009
Team: 18 investment professionals
Offices: 2
Platforms: Innovation and Buyout
Regulation: AMF-registered

Summary written by TrustList from the business's own published information, Sep 2026.

Rankings

Merieux Equity Partners is ranked on 6 TrustList rankings: #8 on 1, #18 on 1, #19 on 1, #21 on 1, #23 on 1 and #24 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Merieux Equity Partners has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 6 rankings

#8of 91
Series b
It is the only one of the top 71 here listing private equity and one of 5 here listing industrial.
Its profile: “- Innovation platform: backs medical innovation from seed stage to series B.”
Of the top 71 here, 42 also cover series and 31 also cover series a; 8 also work in London and 6 also work in New York City.
Behind Inter-Atlantic Group, ahead of Monogram Capital Partners.
#18of 291
Seed stage
It is one of 3 here listing science and one of 4 here listing series b.
Its profile: “- Innovation platform: backs medical innovation from seed stage to series B.”
Of the top 54 here, 18 also cover pre seed and 10 also cover partners; 8 also work in Silicon Valley and 7 also work in San Francisco.
Behind Seedcamp, ahead of Andreessen Horowitz (a16z).
#19of 83
Paris
It is one of 2 here listing healthtech and one of 5 here listing series.
Of the top 65 here, 7 also cover private equity and 7 also cover environmental; 10 also work in Munich and 9 also work in Madrid.
Behind Sunstone Technology Ventures, ahead of InnovaFonds.
#21of 59
Private equity firms
It is the only one of the top 57 here listing seed stage and one of 3 here listing series a.
Of the top 57 here, 12 also cover healthtech and 6 also cover growth stage; 5 also work in Chicago and 3 also work in United States.
Behind TZP Group, ahead of Breakwater Management LP.
#23of 246
Series a
It is one of 13 here listing partners.
Of the top 57 here, 21 also cover seed stage and 9 also cover early stage; 4 also work in Sao Paulo and 3 also work in Europe.
Behind 10x Group, ahead of Knife Capital.
#24of 147
Healthtech investors
It is the only one of the top 64 here listing industrial and one of 6 here listing private equity.
Of the top 64 here, 14 also cover biotech and 10 also cover artificial intelligence; 7 also work in Boston and 6 also work in Hong Kong.
Behind Beecken Petty O’Keefe & Company, ahead of BioStar Capital.